Funded Project Details - FY2021
|Title:|| Therapeutic potential and the critical site of action of non-addicting glibenclamide in neuropathic pain|
J. Marc Simard
|Congressional District Code:
|| April 2020 -
|FY 2021 Funding Amount:
|Total Award Amount
View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER
BACKGROUND: Almost half of Veterans experience chronic pain, which is disproportionately greater than the 25 million Americans in the civilian population who suffer from significant chronic pain. Chronic pain is a common sequela of military- and terror-related injuries. The majority of battlefield wounds involve injuries to exposed limbs, resulting in high rates of neuropathic pain caused by damage to a peripheral nerve. Opioid use disorder and the ongoing “opioid epidemic” are driven in part by...
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.